Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DAC Vision provides one of the most complete portfolios of ophthalmic consumable supplies globally. It has grown through strategic acquisitions and now operates as part of Satisloh Group under EssilorLuxottica. The company focuses on supporting optical professionals with products for lens processing, surfacing, finishing equipment, and coatings[1][2][6].
It does not have clinical results as it does not develop drugs or medical devices requiring clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DAC Vision.